Non-Small Cell Cancer | What I Tell My Patients: Integrating New Research Information into Current Clinical Care — Non-Small Cell Lung Cancer with an EGFR Mutation
Research To Practice | Oncology Videos · Dr. Neil Love
May 10, 20241h 29m
Audio is streamed directly from the publisher (traffic.libsyn.com) as published in their RSS feed. Play Podcasts does not host this file. Rights-holders can request removal through the copyright & takedown page.
Show Notes
Featuring perspectives from Ms Marianne J Davies, Dr Alexander I Spira, Ms Jillian Thompson and Dr Helena Yu, including the following topics:
- Introduction (0:00)
- The Importance of EGFR Testing in Non-Small Cell Lung Cancer (NSCLC) (7:02)
- The Role of Osimertinib in Managing Localized and Locally Advanced NSCLC with an EGFR Mutation (11:58)
- Established First-Line Therapy for Metastatic NSCLC with an EGFR Mutation (32:38)
- Newly Approved and Promising Investigational Approaches to First-Line Therapy for Metastatic NSCLC with an EGFR Mutation (37:45)
- Common Toxicities Associated with Amivantamab (45:07)
- The Current and Future Management of Progressive NSCLC with an EGFR Mutation (55:06)
- Tolerability and Other Practical Considerations with HER3-DXd (1:01:06)
- Treatment for Metastatic NSCLC with EGFR Exon 20 Insertion Mutations (1:18:26)